Brand  (β version)

PDB ID: 5H4J

Hetero Atom Contents

  The number of atoms exceeds 100,000.
  So, it can not be displayed here.

Select unit:

Select hetatm:   

close
information
centroid:
interaction residue:

Select chain:   Sequence  

Data format:   

Color scheme of protein:

Ligands
Code Name Style Show Link
DMS Dimethyl sulfoxide PoSSuM
FKM N-[(1r)-1-[3-(cyclopentyloxy)-phenyl]-ethyl]-3-[(3,4-dihydro-2,4-dioxo-1(2h)-pyrimidinyl)methoxy]-1-propanesulfonamide PoSSuM
IMD Imidazole PoSSuM
ZN Zinc ion PoSSuM
Non-standard Residues
Code Name Show
Glycosylation
Code Name Emphasize
Modification
Code Name Show

Structure summary

Code : 5H4J   PDBj   RCSB PDB   PDBe
Header : HYDROLASE/HYDROLASE INHIBITOR
Title : Crystal structure of Human dUTPase in complex with N-[(1R)-1-[3-(Cyclopentyloxy)-phenyl]-ethyl]-3-[(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)methoxy]-1-propanesulfonamide
Release Data : 2017-11-01
Compound :
mol_id molecule chains synonym
1 Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial A dUTPase,dUTP pyrophosphatase
ec: 3.6.1.23
Source :
mol_id organism_scientific organism_common expression_system
1 Homo sapiens  (taxid:9606) Human Escherichia coli  (taxid:562)
gene: DUT
Authors : Chong, K.T., Miyahara, S., Miyakoshi, H., Fukuoka, M.
Keywords : Hydrolase, Hydrolase inhibitor, HYDROLASE-HYDROLASE INHIBITOR complex
Exp. method : X-RAY DIFFRACTION ( 1.80 Å )
Citation :

TAS-114, a First-in-Class Dual dUTPase/DPD Inhibitor, Demonstrates Potential to Improve Therapeutic Efficacy of Fluoropyrimidine-Based Chemotherapy.

Yano, W.,Yokogawa, T.,Wakasa, T.  et al.
(2018)  Mol. Cancer Ther.  17 : 1683 - 1693

PubMed: 29748212
DOI: 10.1158/1535-7163.MCT-17-0911

Reaction

Chain : A
UniProt : P33316 (DUT_HUMAN)
Reaction: EC: Evidence:
Physiological Direction:
dUTP + H2O = dUMP + diphosphate + H(+) 3.6.1.23 PubMed:17880943, PubMed:8631816, PubMed:8805593
-
Cofactor: Evidence: Note:
Mg(2+) ECO:0000269 | PubMed:8805593
-